These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31938237)

  • 1. Overexpression of long non-coding RNAs DUXAP9 and DUXAP10 is associated with prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Zhu Q; Liu J; Tang J; Guo DL; Li Y; Duan R
    Int J Clin Exp Pathol; 2018; 11(3):1407-1414. PubMed ID: 31938237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNA NRAD1 and LINC00152 are Highly Expressed and Associated with Prognosis in Patients with Hepatocellular Carcinoma.
    Wang B; Yang S; Zhao W
    Onco Targets Ther; 2020; 13():10409-10416. PubMed ID: 33116620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA NEAT1 overexpression is associated with unfavorable prognosis in patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.
    Liu Z; Chang Q; Yang F; Liu B; Yao HW; Bai ZG; Pu CS; Ma XM; Yang Y; Wang TT; Guo W; Zhou XN; Zhang ZT
    Eur J Surg Oncol; 2017 Sep; 43(9):1697-1703. PubMed ID: 28732670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy.
    Dong Y; Yan W; Zhang SL; Zhang MZ; Zhou YP; Ling HH; Ning M; Zhao Y; Huang A; Zhang P
    Oncotarget; 2017 Dec; 8(69):114041-114049. PubMed ID: 29371967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential.
    Fang TT; Sun XJ; Chen J; Zhao Y; Sun RX; Ren N; Liu BB
    Asian Pac J Cancer Prev; 2014; 15(23):10513-24. PubMed ID: 25556502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway.
    Tan L; Tang Y; Li H; Li P; Ye Y; Cen J; Gui C; Luo J; Cao J; Wei J
    Front Oncol; 2021; 11():641833. PubMed ID: 34168980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma.
    Yue C; Liang C; Ge H; Yan L; Xu Y; Li G; Li P; Wei Z; Wu J
    Onco Targets Ther; 2019; 12():4555-4566. PubMed ID: 31354289
    [No Abstract]   [Full Text] [Related]  

  • 11. Upregulation of Long Non-Coding RNA ENST00000429227.1 Is Correlated with Poor Prognosis in Human Hepatocellular Carcinoma.
    Zhao Y; Kong CQ; Ye JZ; Bai T; Luo T; Wang D; Chen M; Wang HF; Wang XB; Liu JJ; Chen J; Luo HL; Li LQ
    Med Sci Monit; 2019 Aug; 25():6539-6546. PubMed ID: 31472071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
    Wang YG; Liu J; Shi M; Chen FX
    J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 14. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
    Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
    Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [OCT4 expression in hepatocellular carcinoma and its clinical significance].
    Huang PZ; Lu CL; Li BK; Hong J; Huang L; Wang L; Zhang Y; Yuan YF
    Chin J Cancer; 2010 Jan; 29(1):111-16. PubMed ID: 20038322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining featured biomarkers associated with vascular invasion in HCC by bioinformatics analysis with TCGA RNA sequencing data.
    Zhang R; Ye J; Huang H; Du X
    Biomed Pharmacother; 2019 Oct; 118():109274. PubMed ID: 31545220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
    Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
    Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
    Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
    Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.